Ortiz wants audit of stem-cell institute
By Sacramento Business Journal,
Sacramento Business Journal
| 02. 22. 2006
State Sen. Deborah Ortiz and 10 other California legislators have asked for an audit of the California Institute for Regenerative Medicine.
CIRM, which oversees stem-cell research money in the state, was created by Proposition 71, which voters approved in 2004.
Ortiz, a Sacramento Democrat, wrote SB 18, a stem-cell oversight bill vetoed by Gov. Arnold Schwarzenegger, with Sen. George Runner, a Republican from Lancaster. In his veto message, Schwarzenegger called the bill's proposed changes to the law that created the stem-cell institute illegal, and urged legislators to pursue an audit through the Joint Legislative Audit Committee.
Ortiz's letter to the audit committee asks for an audit by Sept. 30, 2006 of CIRM and the Independent Citizens' Oversight Committee that governs it.
Ortiz and the others intended to present their request to the committee on Wednesday in Sacramento, but the hearing was postponed, possibly until March 8, according to Ortiz's office.
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...